We further explored the clinical relevance of FABP5 in HCC by analyzing two clinical liver cancer databases and examining clinical samples, which showed that the high expression of FABP5 in patients with liver cancer, compared with peritumoral areas (Fig. 6a, b, Additional file 1: Fig. S9a). Here, FABP5 is linked to liver cancer.